Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation
about
Psoriasin (S100A7) expression and invasive breast cancerThe structure of Ca2+-loaded S100A2 at 1.3-Å resolutionHCaRG, a novel calcium-regulated gene coding for a nuclear protein, is potentially involved in the regulation of cell proliferation.Expression of calcium-binding protein S100A2 in breast lesions.Prediction of epigenetically regulated genes in breast cancer cell linesComparative genomic analyses identify common molecular pathways modulated upon exposure to low doses of arsenic and cadmiumMapping the zinc ligands of S100A2 by site-directed mutagenesis.S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.Genetic polymorphism and protein conformational plasticity in the calmodulin superfamily: two ways to promote multifunctionality.S100 proteins and their influence on pro-survival pathways in cancer.Loss of immunoreactivity for human calmodulin-like protein is an early event in breast cancer development.Directed evolution of improved zinc finger methyltransferases.Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomasRole for tissue-dependent methylation differences in the expression of FOXE1 in nontumoral thyroid glandsExpression and clinical significance of S100A2 and p63 in esophageal carcinomaS100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.S100A2 in cancerogenesis: a friend or a foe?Epigenetic silencing of S100A2 in bladder and head and neck cancersTranscriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3.Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion.S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma.Targeted DNA methylation in human cells using engineered dCas9-methyltransferases.The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity.Evidence for local control of gene expression in the epidermal differentiation complex.Epigenetic regulation of S100 protein expression.Clinical significance of S100A2 expression in gastric cancer.Binding of Ca2+ and Zn2+ to human nuclear S100A2 and mutant proteins.Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma.Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma.Expression profiling of primary non-small cell lung cancer for target identificationS100A2, a Putative Tumor Suppressor Gene, Regulates In Vitro Squamous Cell Carcinoma Migration
P2860
Q22010926-5C0C04F8-F186-4461-8A86-59D8332191D2Q24306778-C81DA578-8A18-431A-989F-DC48A3284BF6Q30890844-E0EDDDB1-0363-45F3-9567-ACF9D0BA250EQ30961562-8D027432-BC1B-4EE6-84E2-13710287AD97Q33595315-CB78160E-9AC4-4761-9E40-BC26CF267EFAQ33860486-1D855339-267E-4FC6-A2CA-8585AB08DFE2Q33899997-027AA951-A7B3-4851-8F01-4759F2847DBCQ34033456-3D17FCDA-E9B8-4B98-97D5-0D2E6345089AQ34334940-8E83517B-7818-41B7-9959-CB8F1DF66840Q34337425-F8305E27-E4B9-4D35-986B-B68A67048FC8Q34786033-D86E8130-C0FA-410A-A60D-7899DE241D13Q35165535-67DE2BB6-0B44-41FB-804C-F6C593A1CC84Q36610866-EAB99C51-F816-4831-81DB-9D4E4EF8B057Q36695771-FC992C02-E417-4405-AFDA-10FC8D77A228Q37309797-6A341ACA-9F85-4854-8286-DD70285B063FQ37335164-020371B6-1253-4E7F-8595-3483A88DA121Q37620665-875AF296-3EEE-485F-BFB1-14E364C85542Q37762477-AE84A575-841A-42E0-A371-B175094BEF15Q38424946-49763FA0-0EF1-4385-87F9-545DDE3EE304Q38621771-2486CE83-B5E5-4090-ACA2-FFA4B2D3BAA6Q39101381-824336DB-BB47-4808-BAF0-E3924033726BQ39322616-56E4D613-DCB9-4CFB-B7A9-5A095088BD5FQ39451596-24E7B8B0-183A-4FC7-BCBE-AE875E5D78D5Q40104894-C1EF3B81-638E-45EF-BF1A-DA0CF92026AFQ40412703-009317A0-501B-43F4-A81B-39C2336CA851Q40699645-E451924D-1B3B-44FD-8DAB-04AC7401BEA2Q41810264-FC51904B-2E95-47BC-89AE-2378B3659C53Q46783208-881E26C4-0422-44CD-BAD3-44247FDC5351Q47828552-D98FA934-12B4-4998-BB77-7AC9A6506481Q51076328-35DA08DF-F7E2-4CDB-8CBA-043B19E44733Q51596002-3B029FA0-4943-4601-AFE4-09AC485C3F6FQ53295389-872407B8-3A2F-4656-B556-DB370706517CQ58068682-198B9888-7254-4E21-B428-8052D24F60DDQ58862285-4900F606-7A77-4926-A558-40929DF740BA
P2860
Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Repression of the candidate tu ...... site-specific hypermethylation
@ast
Repression of the candidate tu ...... site-specific hypermethylation
@en
Repression of the candidate tu ...... site-specific hypermethylation
@en-gb
Repression of the candidate tu ...... site-specific hypermethylation
@nl
type
label
Repression of the candidate tu ...... site-specific hypermethylation
@ast
Repression of the candidate tu ...... site-specific hypermethylation
@en
Repression of the candidate tu ...... site-specific hypermethylation
@en-gb
Repression of the candidate tu ...... site-specific hypermethylation
@nl
prefLabel
Repression of the candidate tu ...... site-specific hypermethylation
@ast
Repression of the candidate tu ...... site-specific hypermethylation
@en
Repression of the candidate tu ...... site-specific hypermethylation
@en-gb
Repression of the candidate tu ...... site-specific hypermethylation
@nl
P2093
P1433
P1476
Repression of the candidate tu ...... site-specific hypermethylation
@en
P2093
P304
P356
10.1016/S0143-4160(97)90063-4
P407
P577
1997-10-01T00:00:00Z